Ligand validation:4BRA

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BRA_MES_B_1395	91%	15%	0.101	0.989	2.02	1.76	1	5	0	0	100%	0.75
4BRA_MES_A_1396	79%	7%	0.142	0.99	2.88	1.93	1	3	1	0	100%	0.75
4BRG_MES_B_1399	99%	15%	0.061	0.989	1.76	1.99	4	3	0	0	100%	1
4BRI_MES_B_1397	96%	19%	0.074	0.983	1.8	1.65	2	3	0	0	100%	1
4BRC_MES_A_1398	95%	25%	0.082	0.986	1.37	1.65	2	3	0	0	100%	1
4BRF_MES_B_1398	94%	8%	0.083	0.982	2.33	2.22	2	6	2	0	100%	0.75
4BRD_MES_B_1398	89%	10%	0.093	0.971	1.81	2.5	3	5	0	0	100%	0.9
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	23%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	21%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	62%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.